Combined MMP9 cytoplasmic and stromal (CS) survival analysis demonstrated that tumours with high cytoplasmic and stromal expression were associated with poor prognosis (p = 0.008; HR = 1.2; 95%CI 1.0–1.4; Fig. 2c). The gene discussed is MMP9; the disease is neoplasm.